why choose us

First received: July 02, 2024

Clinical Trial: Patient-Centric Innovation: Superior Vena Cava Approach in Zero-Fluoroscopy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atrioventricular Nodal Reentrant Tachycardia

Study Type: OBSERVATIONAL


Official Title: Patient-Centric Innovation: Superior Vena Cava Approach in Zero-Fluoroscopy Radiofrequency Catheter Ablation for Atrioventricular Nodal Reentrant Tachycardia

Brief Summary: This study aims to evaluate the viability and therapeutic efficacy of zero-fluoroscopy radiofrequency catheter ablation (RFCA) using the superior vena cava (SVC) approach in patients with atrioventricular nodal reentrant tachycardia (AVNRT).The study compares outcomes between the SVC approach and the conventional inferior vena cava (IVC) approach.Patients diagnosed with AVNRT who underwent RFCA between June 2022 and October 2022 were retrospectively analyzed.The primary outcome measure is the non-inducibility of…

Read more